Cour Pharmaceuticals Development is based in Chicago. It has raised $135M in total funding. Latest round: Series A.
Cour Pharmaceuticals Development is based in Chicago. Cour Pharmaceuticals Development has raised $135M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Cour Pharmaceuticals Development runs through 2024; nothing later has been disclosed. Investors on record include Lumira Ventures, Alpha Wave Ventures, Roche Venture Fund, Pfizer, Bristol Myers Squibb. 5 distinct backers are named across the disclosed rounds.
We update the Cour Pharmaceuticals Development record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Chicago and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026